Caliper Life Sciences has announced the Quantum FX, a standalone microCT system for preclinical imaging.
The Quantum FX is a low-dose, microCT system that provides researchers with a 3D anatomical view of disease activity, tumour development and therapeutic response over multiple time points during the course of a study.
Quantum offers complementary 3D anatomical precision for current imaging applications, while also expanding Caliper's offering in areas such as skeletal, vascular and respiratory disease.
Quantum FX uses ultra-fast, sensitive and low-dosage CT technology from Rigaku to create high-resolution 3D images with minimal X-ray exposure.
With Quantum, multiple images can be taken at many steps in a time-course study with minimal impact on the animal.
The use of Quantum low-dose CT in conjunction with IVIS Spectrum can provide, for example, co-registered images of tumour development that reveal the early stages of disease development without impacting the biology of the animal.
